US 11,654,107 B2
Animal treat composition for delivery of oral medication
Mark A. Levin, Omaha, NE (US); and Joanne N. Levin, Omaha, NE (US)
Assigned to JMN Technologies LLC, Omaha, NE (US)
Filed by JMN Technologies LLC, Omaha, NE (US)
Filed on Jun. 3, 2020, as Appl. No. 16/892,220.
Claims priority of provisional application 62/856,594, filed on Jun. 3, 2019.
Prior Publication US 2020/0375893 A1, Dec. 3, 2020
Int. Cl. A61K 9/00 (2006.01); A61K 9/20 (2006.01); A23K 40/25 (2016.01); A23K 20/163 (2016.01); A23K 10/33 (2016.01); A23K 10/20 (2016.01)
CPC A61K 9/0056 (2013.01) [A23K 10/20 (2016.05); A23K 10/33 (2016.05); A23K 20/163 (2016.05); A23K 40/25 (2016.05); A61K 9/2018 (2013.01); A61K 9/2054 (2013.01); A61K 9/2059 (2013.01); A61K 9/2063 (2013.01); A61K 9/2068 (2013.01); A61K 9/2095 (2013.01); A61K 9/2072 (2013.01)] 12 Claims
OG exemplary drawing
 
1. An animal treat for delivery of oral medication to an animal, the treat comprising a semi-solid adhesive inner portion surrounded by a non-sticky outer portion, wherein the adhesive inner portion comprises: from about 5% w/w to about 50% w/w of one or more sugars; a water content of about 20% w/w or more; 10% w/w or more of a starch comprising a ratio of amylopectin to amylose ranging from about 80% w/w amylopectin: 20% w/w amylose, to about 99% w/w amylopectin: 1% w/w amylose; from about 1% w/w to about 3% w/w gelatin; and a fat content of about 2% w/w or less, wherein the water activities of the adhesive inner portion and the non-sticky outer portion range from about 0.75 to about 0.8, and wherein an oral medication inserted into the adhesive inner portion is retained in the treat when administered to an animal.